Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06040125 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

StatusRecruiting
PhaseNot applicable
Started2024-01-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Aug 28, 2026 → Aug 28, 2027
See other at-risk trials from Dana-Farber Cancer Institute

Amendment history

2026-09-09
Study Status, Contacts/Locations v5
Primary completion pushed: 2026-08-28 → 2027-08-28
Completion pushed: 2027-02-28 → 2028-02-28
Study sitescontacts updated at 1 of 3 sites
2026-03-10
Study Status v4
Primary completion date2026-02-28→2026-08-28
2025-02-25
Study Status v3
Re-verified, no change to tracked fields
2024-02-26
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-01→confirmed 2024-01-01
Study sitesdetails revised at 3 of 3 sites
2024-01-03
Study Status v1
Start date2023-11→2024-01
2023-09-13
Original filing
The purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utilizing resistance and functional exercises and self-directed aerobic exercise will improve frailty and sarcopenic status and disease progression outcomes among pre-frail/frail metastatic prostate cancer patients receiving androgen deprivation therapy (ADT). The names of the study intervention involved in this study is: • Supervised circuit training (aerobic and resistance exercise regimen)
Trial Details
NCT Number NCT06040125
Lead Sponsor Dana-Farber Cancer Institute
Collaborators: Prostate Cancer Foundation
Conditions PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma
Enrollment 80 participants
Start Date 2024-01-01
Primary Completion 2027-08-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-09-10